However, hopes of leptin therapy for common forms of obesity have not been fulfilled, although recombinant human leptin received approval by the U.S. Food and Drug Administration in 2014 for the treatment of generalized lipodystrophy (7, 24). This evidence concerns the gene LEP and generalized lipodystrophy.